{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:42:51Z","timestamp":1767084171288,"version":"3.41.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1197","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Elevated serum ferritin levels are associated with various clinical conditions, including inflammation and tissue damage. This study aims to investigate the distribution of diagnoses associated with hyperferritinemia in different clinical contexts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients admitted to Severance Hospital, Seoul, Korea, between January and December 2017, with serum ferritin levels of 500\u00a0ng\/ml or higher, were included. A retrospective chart review was conducted to collect demographic information, underlying diseases, ferritin levels, and febrile status. Patients were categorized by age (\u226520 vs. &amp;lt;20\u00a0years), febrile status (febrile vs. afebrile), and ferritin cut-off levels (\u2265500, \u22651000, \u22652000, \u22653000, and\u2009\u2265\u200910\u2009000\u00a0ng\/ml). Diagnoses were classified into 10 categories, and their distribution was analyzed across patient subgroups with different characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 2044 patients with hyperferritinemia, solid organ malignancies (37.1%) were the most common cause, followed by infections (23.4%) and hematologic disorders (14.9%). Younger patients had higher ferritin levels and a greater prevalence of hematologic (38.8% vs. 12.9%) and rheumatic diseases (6.6% vs. 3.7%). Febrile patients exhibited higher ferritin levels and more frequent diagnoses of infections (27.2% vs. 12.5%), hematologic (16.2% vs. 11.2%), and rheumatic diseases (4.7% vs. 1.5%). As ferritin levels increased, hematologic and rheumatic diseases became more prevalent, although other diagnoses remained common across ferritin levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Hyperferritinemia has a broad range of underlying causes, with diagnostic distributions varying by age, febrile status, and ferritin levels. These findings underscore the importance of comprehensive evaluation and contextual interpretation for patients with unexplained hyperferritinemia, advocating for a tailored diagnostic approach based on clinical context.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/postmj\/qgae194","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:02:35Z","timestamp":1750816955000},"page":"612-619","source":"Crossref","is-referenced-by-count":1,"title":["Unraveling the differential diagnosis of hyperferritinemia: insights from a retrospective study at a tertiary care hospital"],"prefix":"10.1093","volume":"101","author":[{"given":"Lucy Eunju","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason Jungsik","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-2181","authenticated-orcid":false,"given":"Seung Min","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, St. Vincent\u2019s Hospital, College of Medicine, The Catholic University of Korea , 222 Banpo-daero, Seocho-gu, Seoul 06591 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"2025062422023386600_ref1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/bmj.4.5834.206","article-title":"Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload","volume":"4","author":"Jacobs","year":"1972","journal-title":"Br Med J"},{"key":"2025062422023386600_ref2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","article-title":"Causes and significance of markedly elevated serum ferritin levels in an academic medical center","volume":"19","author":"Moore","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"2025062422023386600_ref3","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00277-017-3072-0","article-title":"Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis","volume":"96","author":"Otrock","year":"2017","journal-title":"Ann Hematol"},{"key":"2025062422023386600_ref4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/s0002-9343(99)80015-1","article-title":"Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance","volume":"98","author":"Lee","year":"1995","journal-title":"Am J Med"},{"key":"2025062422023386600_ref5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/bjh.15166","article-title":"Investigation and management of a raised serum ferritin","volume":"181","author":"Cullis","year":"2018","journal-title":"Br J Haematol"},{"key":"2025062422023386600_ref6","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","article-title":"Marked hyperferritinemia does not predict for HLH in the adult population","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"key":"2025062422023386600_ref7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1157\/13060470","article-title":"Clinical significance of increased serum ferritin levels","volume":"122","author":"Ramirez","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"2025062422023386600_ref8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaut.2007.11.003","article-title":"New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity","volume":"30","author":"Recalcati","year":"2008","journal-title":"J Autoimmun"},{"key":"2025062422023386600_ref9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","journal-title":"Int Immunol"},{"key":"2025062422023386600_ref10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/jcb.21499","article-title":"Macrophages function as a ferritin iron source for cultured human erythroid precursors","volume":"103","author":"Leimberg","year":"2008","journal-title":"J Cell Biochem"},{"key":"2025062422023386600_ref11","doi-asserted-by":"publisher","first-page":"103114","DOI":"10.1016\/j.autrev.2022.103114","article-title":"Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications","volume":"21","author":"Ruscitti","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2025062422023386600_ref12","doi-asserted-by":"publisher","first-page":"102778","DOI":"10.1016\/j.jaut.2021.102778","article-title":"Ferritin\u2014from iron, through inflammation and autoimmunity, to COVID-19","volume":"126","author":"Mahroum","year":"2022","journal-title":"J Autoimmun"},{"key":"2025062422023386600_ref13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.13069","article-title":"Eppur Si Muove: ferritin is essential in modulating inflammation","volume":"191","author":"Sharif","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2025062422023386600_ref14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"key":"2025062422023386600_ref15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/annrheumdis-2020-217618","article-title":"Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?","volume":"79","author":"Ruscitti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025062422023386600_ref16","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00296-021-04935-y","article-title":"Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience","volume":"41","author":"Uskudar Cansu","year":"2021","journal-title":"Rheumatol Int"},{"key":"2025062422023386600_ref17","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1097\/MPH.0b013e31824227b9","article-title":"Serum ferritin is a cost-effective laboratory marker for hemophagocytic lymphohistiocytosis in the developing world","volume":"34","author":"Switala","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"2025062422023386600_ref18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1039\/c3mt00347g","article-title":"Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics: integrated biometal science"},{"key":"2025062422023386600_ref19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1155\/2013\/915389","article-title":"Diagnostic use of serum ferritin levels to differentiate infectious and noninfectious diseases in patients with fever of unknown origin","volume":"34","author":"Kim","year":"2013","journal-title":"Dis Markers"},{"key":"2025062422023386600_ref20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/00365540601169729","article-title":"Fever of unknown origin (FUO): diagnostic importance of serum ferritin levels","volume":"39","author":"Cunha","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"2025062422023386600_ref21","first-page":"35","article-title":"Fever of unknown origin--reexamined and redefined","volume":"11","author":"Durack","year":"1991","journal-title":"Curr Clin Top Infect Dis"},{"key":"2025062422023386600_ref22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","article-title":"Serum ferritin: past, present and future","volume":"1800","author":"Wang","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2025062422023386600_ref23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"2025062422023386600_ref24","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s11845-024-03698-2","article-title":"Predictors of mortality, mortality rates, and clinical characteristics of adult patients with extreme hyperferritinemia","volume":"193","author":"G\u00fcven","year":"2024","journal-title":"Ir J Med Sci"},{"key":"2025062422023386600_ref25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2025062422023386600_ref26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2025062422023386600_ref27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000536287","article-title":"Prognostic factors of adult Hemophagocytic Lymphohistiocytosis and clinical utility of HLH-2004 diagnostic criteria and HScore: a real-world Multicenter study from Thailand","volume":"147","author":"Jongdee","year":"2024","journal-title":"Acta Haematol"},{"key":"2025062422023386600_ref28","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001911","article-title":"Predictors of the severity of the course of COVID-19: demographic factors, clinical signs and laboratory markers","volume":"73","author":"Bartoszewicz","year":"2024","journal-title":"J Med Microbiol"},{"key":"2025062422023386600_ref29","doi-asserted-by":"publisher","first-page":"1368719","DOI":"10.3389\/fmed.2024.1368719","article-title":"Association of serum ferritin and all-cause mortality in AKI patients: a retrospective cohort study","volume":"11","author":"Ren","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"2025062422023386600_ref30","doi-asserted-by":"publisher","first-page":"953730","DOI":"10.3389\/fimmu.2022.953730","article-title":"Activation mechanisms of monocytes\/macrophages in adult-onset still disease","volume":"13","author":"Tsuboi","year":"2022","journal-title":"Front Immunol"},{"key":"2025062422023386600_ref31","doi-asserted-by":"publisher","first-page":"626812","DOI":"10.3389\/fimmu.2020.626812","article-title":"Iron metabolism in the tumor microenvironment: contributions of innate immune cells","volume":"11","author":"Liang","year":"2020","journal-title":"Front Immunol"},{"key":"2025062422023386600_ref32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbcan.2013.07.002","article-title":"The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis","volume":"1836","author":"Alkhateeb","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2025062422023386600_ref33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.31083\/j.fbl2808182","article-title":"An overview of heavy chain ferritin in cancer","volume":"28","author":"Shi","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2025062422023386600_ref34","doi-asserted-by":"publisher","first-page":"106939","DOI":"10.1016\/j.intimp.2020.106939","article-title":"Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment","volume":"88","author":"Li","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"2025062422023386600_ref35","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"2025062422023386600_ref36","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American College of Rheumatology Classification Criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025062422023386600_ref37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1056\/NEJMra2111003","article-title":"Fever of unknown origin","volume":"386","author":"Haidar","year":"2022","journal-title":"N Engl J Med"},{"key":"2025062422023386600_ref38","doi-asserted-by":"publisher","first-page":"152066","DOI":"10.1016\/j.semarthrit.2022.152066","article-title":"Rheumatic disorders among patients with fever of unknown origin: a systematic review and meta-analysis","volume":"56","author":"Betrains","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025062422023386600_ref39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12879-019-4285-8","article-title":"Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005-2015 systematic review","volume":"19","author":"Fusco","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2025062422023386600_ref40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00006231-200603000-00002","article-title":"Fever of unknown origin: a systematic review of the literature for 1995-2004","volume":"27","author":"Gaeta","year":"2006","journal-title":"Nucl Med Commun"},{"key":"2025062422023386600_ref41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2025062422023386600_ref42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American College of Rheumatology\/paediatric rheumatology international trials organisation collaborative initiative","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/101\/1197\/612\/63547774\/qgae194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/101\/1197\/612\/63547774\/qgae194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:02:36Z","timestamp":1750816956000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/101\/1197\/612\/7943405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":42,"journal-issue":{"issue":"1197","published-online":{"date-parts":[[2025,1,6]]},"published-print":{"date-parts":[[2025,6,22]]}},"URL":"https:\/\/doi.org\/10.1093\/postmj\/qgae194","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"type":"print","value":"0032-5473"},{"type":"electronic","value":"1469-0756"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,1,6]]}}}